While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. That said, here are two profitable companies that generate reliable profits without sacrificing growth and one that may face some trouble.
One Stock to Sell:
Elanco (ELAN)
Trailing 12-Month GAAP Operating Margin: 1.6%
Originally established as a division of pharmaceutical giant Eli Lilly before becoming independent in 2018, Elanco Animal Health (NYSE: ELAN) develops and sells medications, vaccines, and other health products for pets and farm animals across more than 90 countries.
Why Does ELAN Fall Short?
- Sales trends were unexciting over the last five years as its 2% annual growth was below the typical healthcare company
- Efficiency has decreased over the last five years as its adjusted operating margin fell by 3.5 percentage points
- Push for growth has led to negative returns on capital, signaling value destruction
Elanco is trading at $24.39 per share, or 20x forward P/E. Check out our free in-depth research report to learn more about why ELAN doesn’t pass our bar.
Two Stocks to Watch:
Cardinal Health (CAH)
Trailing 12-Month GAAP Operating Margin: 1%
Operating as a critical link in the healthcare supply chain since 1979, Cardinal Health (NYSE: CAH) distributes pharmaceuticals and manufactures medical products for hospitals, pharmacies, and healthcare providers across the global healthcare supply chain.
Why Does CAH Stand Out?
- Massive revenue base of $254.2 billion in a highly regulated sector makes the company difficult to replace, giving it meaningful negotiating power
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 14.6% exceeded its revenue gains over the last five years
At $235.23 per share, Cardinal Health trades at 18.3x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
Kinder Morgan (KMI)
Trailing 12-Month GAAP Operating Margin: 29%
Operating what amounts to the toll roads of the energy industry, Kinder Morgan (NYSE: KMI) transports natural gas, refined petroleum products, and crude oil through its pipeline network across North America.
Why Are We Fans of KMI?
- Enormous revenue base of $17.96 billion provides significant leverage in supplier negotiations
- EBITDA margin improvement of 9.1 percentage points over the last five years demonstrates its ability to scale efficiently
- Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends
Kinder Morgan’s stock price of $31.00 implies a valuation ratio of 21.1x forward P/E. Is now a good time to buy? See for yourself in our in-depth research report, it’s free.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
